RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Morris Benveniste to Receptors, N-Methyl-D-Aspartate

This is a "connection" page, showing publications Morris Benveniste has written about Receptors, N-Methyl-D-Aspartate.
  1. Nahum-Levy R, Tam E, Shavit S, Benveniste M. Glutamate but not glycine agonist affinity for NMDA receptors is influenced by small cations. J Neurosci. 2002 Apr 01; 22(7):2550-60.
    View in: PubMed
    Score: 0.201
  2. Sheinin A, Nahum-Levy R, Shavit S, Benveniste M. Specificity of putative partial agonist, 1-aminocyclopropanecarboxylic acid, for rat N-methyl-D-aspartate receptor subunits. Neurosci Lett. 2002 Jan 11; 317(2):77-80.
    View in: PubMed
    Score: 0.198
  3. Sheinin A, Shavit S, Benveniste M. Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine. Neuropharmacology. 2001 Aug; 41(2):151-8.
    View in: PubMed
    Score: 0.192
  4. Nahum-Levy R, Lipinski D, Shavit S, Benveniste M. Desensitization of NMDA receptor channels is modulated by glutamate agonists. Biophys J. 2001 May; 80(5):2152-66.
    View in: PubMed
    Score: 0.188
  5. Nahum-Levy R, Fossom LH, Skolnick P, Benveniste M. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors. Mol Pharmacol. 1999 Dec; 56(6):1207-18.
    View in: PubMed
    Score: 0.171
  6. Benveniste M, Mayer ML. Multiple effects of spermine on N-methyl-D-aspartic acid receptor responses of rat cultured hippocampal neurones. J Physiol. 1993 May; 464:131-63.
    View in: PubMed
    Score: 0.108
  7. Benveniste M, Mayer ML. Effect of extracellular pH on the potency of N-methyl-D-aspartic acid receptor competitive antagonists. Mol Pharmacol. 1992 Oct; 42(4):679-86.
    View in: PubMed
    Score: 0.104
  8. Benveniste M, Mayer ML. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction. Br J Pharmacol. 1991 Sep; 104(1):207-21.
    View in: PubMed
    Score: 0.096
  9. Benveniste M, Mayer ML. Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Two binding sites each for glutamate and glycine. Biophys J. 1991 Mar; 59(3):560-73.
    View in: PubMed
    Score: 0.093
  10. Benveniste M, Clements J, Vyklick? L, Mayer ML. A kinetic analysis of the modulation of N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurones. J Physiol. 1990 Sep; 428:333-57.
    View in: PubMed
    Score: 0.090
  11. Mott DD, Benveniste M, Dingledine RJ. pH-dependent inhibition of kainate receptors by zinc. J Neurosci. 2008 Feb 13; 28(7):1659-71.
    View in: PubMed
    Score: 0.075
  12. Benveniste M, Dingledine R. Limiting stroke-induced damage by targeting an acid channel. N Engl J Med. 2005 Jan 06; 352(1):85-6.
    View in: PubMed
    Score: 0.061
  13. Morel C, Sherrin T, Kennedy NJ, Forest KH, Avcioglu Barutcu S, Robles M, Carpenter-Hyland E, Alfulaij N, Standen CL, Nichols RA, Benveniste M, Davis RJ, Todorovic C. JIP1-Mediated JNK Activation Negatively Regulates Synaptic Plasticity and Spatial Memory. J Neurosci. 2018 04 11; 38(15):3708-3728.
    View in: PubMed
    Score: 0.038
  14. Popik P, Layer RT, Fossom LH, Benveniste M, Geter-Douglass B, Witkin JM, Skolnick P. NMDA antagonist properties of the putative antiaddictive drug, ibogaine. J Pharmacol Exp Ther. 1995 Nov; 275(2):753-60.
    View in: PubMed
    Score: 0.032
  15. Mayer ML, Benveniste M, Patneau DK, Vyklicky L. Pharmacologic properties of NMDA receptors. Ann N Y Acad Sci. 1992 May 11; 648:194-204.
    View in: PubMed
    Score: 0.025
  16. Vyklick? L, Benveniste M, Mayer ML. Modulation of N-methyl-D-aspartic acid receptor desensitization by glycine in mouse cultured hippocampal neurones. J Physiol. 1990 Sep; 428:313-31.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support